Skip to main content

Table 2 The immunohistochemical characteristics of the PBL cases

From: Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia

Pt.#

CD45

CD20

CD79a

PAX5

CD3

CD38

CD138

MUM1

EMA

CD56

KAPPA/ LAMBDA

ALK1

CYCLIN D1

EBV- LMP1

HHV8

CD10 BCL2 BCL6

Ki-67

Case 1

─

─

─

─

─

+

+

+

─

+

Lambda

─

─

─

─

─

>90 %

Case 2

+

─

─

─

─

+

+

+

+

─

Lambda

─

─

─

+

─

>80 %

Case 3

─

─

─

─

─

+

+

+

─

─

ND

─

─

─

─

─

>80 %

Case 4

+

─

─

+/─

─

+

+

+

+

─

Lambda

─

─

─

─

─

>80 %

Case 5

+/─

─

─

─

─

+

+

+

+

─

ND

─

─

─

─

─

>70 %

Case 6

─

─

+/─

─

─

+

+

+

─

─

Lambda

─

─

─

─

─

>70 %

Case 7

─

─

+/─

+/─

─

+

+

+

─

─

Kappa

─

─

─

─

─

>70 %

Case 8

─

─

─

─

─

+

+

+

+

─

Kappa

─

─

─

─

─

>70 %

  1. ND Not done
  2. +/−: Weak positive, +: Positive, −: Negative